ResMed Inc. (RMD)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:25PM EDT. Market open.
| Previous close | 238.86 |
| Open | 238.26 |
| Bid | 238.68 x 1800 |
| Ask | 238.97 x 900 |
| Day's range | 236.62 - 239.11 |
| 52-week range | 132.24 - 255.18 |
| Volume | |
| Avg. volume | 1,007,631 |
| Market cap | 35.133B |
| Beta (5Y monthly) | 0.69 |
| PE ratio (TTM) | 34.50 |
| EPS (TTM) | 6.93 |
| Earnings date | 24 Oct 2024 - 28 Oct 2024 |
| Forward dividend & yield | 2.12 (0.89%) |
| Ex-dividend date | 15 Aug 2024 |
| 1y target est | 237.93 |
ZacksZacks.com featured highlights Ferrari, Vertex, ResMed and Hubbel
Ferrari, Vertex, ResMed and Hubbel have been highlighted in this Screen of The Week article.
Barrons.comResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker.
Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..
ZacksResMed (RMD) Upgraded to Buy: What Does It Mean for the Stock?
ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2024 Yahoo. All rights reserved.